First of all, a lot of the technology related to mRNA vaccines and mRNA generally has come from the Vancouver area and the University of British Columbia. There are number of companies involved with lipid nanoparticles—which are an important way of encasing the RNA—that are present, as well as other companies, so that is very much there.
On the investments that are being made, a number of them are being made in RNA/mRNA capabilities, such as Precision NanoSystems is doing in Vancouver. As we looked at some of the other investments and provided advice to some of the other contract development and manufacturing organizations, we've looked at “do they have RNA technology and will they be able to pivot in that direction?” For the investments that are being made now, RNA is included in those areas of investment.